[go: up one dir, main page]

AU3114295A - Methods of prognosing the course and degree of dementia in patients with beta-amyloid-related diseases - Google Patents

Methods of prognosing the course and degree of dementia in patients with beta-amyloid-related diseases

Info

Publication number
AU3114295A
AU3114295A AU31142/95A AU3114295A AU3114295A AU 3114295 A AU3114295 A AU 3114295A AU 31142/95 A AU31142/95 A AU 31142/95A AU 3114295 A AU3114295 A AU 3114295A AU 3114295 A AU3114295 A AU 3114295A
Authority
AU
Australia
Prior art keywords
prognosing
amyloid
dementia
beta
patients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU31142/95A
Inventor
John Hardy
Gareth Wyn Roberts
Maureen Claire Royston
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
University of South Florida St Petersburg
Original Assignee
SmithKline Beecham Ltd
University of South Florida
University of South Florida St Petersburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd, University of South Florida, University of South Florida St Petersburg filed Critical SmithKline Beecham Ltd
Publication of AU3114295A publication Critical patent/AU3114295A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU31142/95A 1994-07-20 1995-07-12 Methods of prognosing the course and degree of dementia in patients with beta-amyloid-related diseases Abandoned AU3114295A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9414624 1994-07-20
GB9414624A GB9414624D0 (en) 1994-07-20 1994-07-20 Novel method
PCT/EP1995/002823 WO1996002670A1 (en) 1994-07-20 1995-07-12 Methods of prognosing the course and degree of dementia in patients with beta-amyloid-related diseases

Publications (1)

Publication Number Publication Date
AU3114295A true AU3114295A (en) 1996-02-16

Family

ID=10758607

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31142/95A Abandoned AU3114295A (en) 1994-07-20 1995-07-12 Methods of prognosing the course and degree of dementia in patients with beta-amyloid-related diseases

Country Status (3)

Country Link
AU (1) AU3114295A (en)
GB (1) GB9414624D0 (en)
WO (1) WO1996002670A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7049078B2 (en) 1994-04-27 2006-05-23 Judés Poirier Apolipoprotein E polymorphism and treatment of alzheimer's disease
GB9408465D0 (en) * 1994-04-27 1994-06-22 Univ Mcgill Apolipoprotein e polymorphism & treatment of alzheimer's disease
US6022683A (en) * 1996-12-16 2000-02-08 Nova Molecular Inc. Methods for assessing the prognosis of a patient with a neurodegenerative disease
CA2236274A1 (en) * 1995-11-01 1997-05-09 Kos Pharmaceuticals, Inc. Apolipoprotein e2 and treatment of alzheimer's disease
AT404993B (en) * 1997-01-13 1999-04-26 Immuno Ag METHOD FOR DETERMINING A PROTEIN WITH A MUTATION
EP1117840A1 (en) 1998-10-01 2001-07-25 Variagenics, Inc. Methods for treating or identifying a subject at risk for a neurological disease by determining the presence of a variant gpiiia and/or variant gpiib allele
CA3040687A1 (en) 2016-10-14 2018-04-19 Childrens' Medical Center Corporation Compositions and methods for treating diseases and disorders of the central nervous system
AU2018210853B2 (en) 2017-01-17 2023-09-28 Children's Medical Center Corporation Compositions and methods for treating lysosomal storage diseases and disorders
EP3571310A4 (en) 2017-01-17 2020-12-16 Children's Medical Center Corporation COMPOSITIONS AND METHODS OF DIAGNOSIS AND TREATMENT OF PEROXISOMAL DISEASES
CN114555100A (en) * 2019-10-01 2022-05-27 儿童医疗中心有限公司 Compositions and methods for treating alzheimer's disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE625212T1 (en) * 1992-10-13 2000-11-02 Duke University, Durham METHOD FOR DISCOVERING DISEASE OF ALZHEIMER.
CA2170727A1 (en) * 1993-08-31 1995-03-09 Warren J. Strittmatter Methods and compositions for binding tau and map2c proteins
CA2111503A1 (en) * 1993-12-15 1995-06-16 Mcgill University Apolipoprotein e polymorphism and alzheimer's disease

Also Published As

Publication number Publication date
WO1996002670A1 (en) 1996-02-01
GB9414624D0 (en) 1994-09-07

Similar Documents

Publication Publication Date Title
AU4054297A (en) Manipulations of nitrosative and oxidatives stress in the treatment of disease
AU2160297A (en) Method for the production of activated marked tumor-specific t cells and use thereof in treatment of tumors
AU2071097A (en) Cannula and method of manufacture and use
AU3725997A (en) S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders
AU2103097A (en) Cinnoline derivatives and use as medicine
AU5687896A (en) Use of alpha 1L-agonists in the treatment of incontinence
AU6566094A (en) Heterocyclic derivatives in the treatment of ischaemia and related diseases
AU3099997A (en) The use of tcet in the prophylaxis and treatment of allergies
AU3114295A (en) Methods of prognosing the course and degree of dementia in patients with beta-amyloid-related diseases
AU3118297A (en) Sok-1 and methods of use
AU3241895A (en) Apoptosis related protein bcl-y, and methods of use thereof
AU3430495A (en) The use of VWF-containing concentrates as a therapy which is employed in combination with antithrombotic and fibrinolytic therapy
AU3261097A (en) Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders
AU3634595A (en) Bis-oxazolidines and their use
AU2512495A (en) Therapeutic phenoxyalkylazoles and phenoxyalkylazines
AU4505996A (en) 7-vinylidene cephalosporins and methods of using the same
AU3261197A (en) Piperidine acetic acid derivatives and their use in the treatment of thromb otic disorders
AU6822796A (en) T-pa polymorphism and use thereof in diagnosis of risk of thrombus associated disease
AU4118393A (en) Human crabp-I and crabp-II
AU2705495A (en) Use of rooperol and hypoxoside and their derivatives in the treatment of inflammatory
AU5168193A (en) Human homologs of the transducin-like enhancer of split gene and methods based thereon
AU6491890A (en) Use of arylalkylamides in the treatment of neurodegenerative diseases
AU2115197A (en) Compositions and methods useful in the detection and/or treatment of cancerous conditions
IL116134A0 (en) Iminooxybenzylcrotonate esters their preparation and their use
AU641157B2 (en) 2-imino-thiadiazoline-5-sulphonamides and their use in the treatment of glaucoma